Arginine Hydrochloride
Arginine Hydrochloride is a pharmaceutical drug with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Arginine Replacement Therapy in COVID-19
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Novel Treatment of Advanced Hepatocellular Carcinoma
Prevention of Cancer Development and Progression
Treatment of Intermediate-stage Hepatocellular Carcinoma
Clinical Trials (8)
Arginine Replacement Therapy in COVID-19
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Novel Treatment of Advanced Hepatocellular Carcinoma
Prevention of Cancer Development and Progression
Treatment of Intermediate-stage Hepatocellular Carcinoma
Treatment of Advanced Hepatocellular Carcinoma
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8